The 2022 BioNTX iC3 Summit will bring together leaders and changemakers to “accelerate life sciences in North Texas” »Dallas Innovates

The North Texas bioscience and healthcare innovation community is home to nationally recognized start-ups and companies that are well-positioned to attract additional industry growth.

BioNTX, a North Texas business organization that is a hub for building the industry and its ecosystem, is a major source of support and resources for the community.

Its flagship event, the iC3 Life Science Summit brings together biotech leaders and changemakers. Industry experts will discuss insights, insights and strategies. The two-day forum will be held at the Gaylord Texan in Grapevine on September 22-23.

iC³ = Innovation x Capital x Collaboration x Commercialization

BioNTX CEO Kathleen Otto said the naming of the summit was intentional: the combination of innovation, capital, collaboration and commercialization is the very reason the life sciences industry is flourishing in North Texas.

Science is vital to the future of humanity and the economic well-being of the region, says BioNTX. The goal of this year’s summit, Accelerating Life Sciences in North Texas, supports this.

The iC3 Life Sciences Summit is a place where leaders come together to share ideas, exhibit the broad spectrum of North Texas bioscience research, and learn about the latest innovations, products and services.

Catch the next wave of Texas tech at iC3

The flagship event will host startups through large multinationals representing industry sectors such as biotech and pharma, as well as healthcare companies, academic research institutes, innovators, investors, supplier partners and other leaders.

iC3 is designed to foster partnerships and collaboration. Attendees can connect with innovative industry leaders and exchange insights, insights, trends, and stories while building business relationships.

Speakers and topics announced

Keynote speakers include:

Jose Arrieta
Former Chief Information Officer and Chief Data Officer
US Department of Health and Human Services

Brett Giroir, MD
Former Assistant Secretary for Health and Admiral
Corps commissioned by the United States Public Health Service

Key topics include:

The State of Biotechnology in Texas
How Texas is working together to bring national attention to the financial resources, infrastructure, community, and talent our state has to offer.

Strategies for Your Success, Financing in Today’s Market
Learn from experts in the field how to develop your fundraising strategy to secure funding to further your trail.

Enterprise Licensing Process and Alliance Management
Our panel provides information on how to find the right people within a potential partner organization, the negotiation process and advice on how to maintain good alliance relationships.

FDA Hot Topics
The FDA has many initiatives and priorities that impact the biotechnology industry. Learn about today’s hottest FDA topics from our regulatory and legal experts.

Impact of innovation on clinical trials, accelerating patient outcomes
Clinical research sponsors, study sites and service providers continue to face challenges such as retention of study participants, lack of diversity within participant populations, compliance with regulatory requirements and data collection and management. And above all, maintain trust with patients. A panel of vendors, sponsors and CROs will examine how innovation and technology can be deployed to meet the trend of challenges.

Market assessment, access strategies and product launch
Provide real-world perspectives on best practices in market assessment and development; market access strategies and launch preparations.

Tackle Texas Talent: Ensuring Biomakers Don’t Look Elsewhere
Texas’ reputation for its business-friendly climate, available real estate, and cutting-edge life science research make it a frequent site-selection prospect for biopharmaceutical manufacturing. However, building a strong biopharmaceutical reputation and securing more of these deals will require better alignment, engagement and discussion among legislators, regional economic development organizations, investors and the many industry associations. focused on life sciences in the state. This session will bring together economic development actors, workforce development experts, and biopharmaceutical companies with a presence in Texas to discuss what works, what doesn’t, and what opportunities we should collectively explore to grow Texas’ reputation as a leading state in biopharmaceutical manufacturing.

New investments and strategies to advance health equity

DFW Airport Pharmaceutical Logistics Strategy and Support for the Region’s Life Sciences Sector
DFW Airport will discuss its pharmaceutical logistics and handling strategy and why it supports the North Texas life sciences sector.

Introducing TechStars
UNT’s Health Sciences Center in Fort Worth recently partnered with Techstars, which is a global investment firm that provides access to capital, one-on-one mentoring, and customized programs for start-up entrepreneurs. . Find out how Techstars plans to help North Texas entrepreneurs!

Preparing your Start Up for the presentation to investors
Hear from investors and executives about the current funding landscape and expectations for the rest of the year. A panel will also explore the risks/benefits of a variety of financing options and provide information on how to explore these options.

Transfer office showcase and pitch competition
Innovation in North Texas continues to grow. Hear from North Texas academic institutions showcase their best technologies available for licensing, collaboration, and/or acquisition.

You can also meet NTX 2022 Rising Stars. These next-gen leaders will showcase remarkable achievements.

Registration and information

Go here for more information and to stay up to date on the lineup.
Get tickets here.

Dallas Innovates is a media sponsor of the BioNTX iCE Life Science Summit.

Join the list.
Dallas innovates, every day.

Sign up to keep an eye on what’s new and coming to Dallas-Fort Worth, every day.

Comments are closed.